Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sifelani Malima"'
Autor:
Rebecca Howett, Emily A. Krogstad, Opelo Badubi, Alida M. Gertz, Caitlin Bawn, Aamirah Mussa, Tiroyaone Kgaswanyane, Sifelani Malima, Tshego Maotwe, Lesego Mokganya, Doreen Ramogola-Masire, Chelsea Morroni
Publikováno v:
Frontiers in Global Women's Health, Vol 2 (2021)
Introduction: This study explored implant user and healthcare provider experiences of accessing and providing contraceptive implant removal services in Gaborone, Botswana, following introduction of the implant in the public sector in 2016. We sought
Externí odkaz:
https://doaj.org/article/1437da3d5e39478da7f92a8cdb9d1c0b
Autor:
G Justus Hofmeyr, Rebecca Jane Ryan, Aamirah Mussa, Bame Bame, Sifelani Malima, Thabo Moloi, Rebecca Luckett, Ndiwo B Memo, Badani Moreri-Ntshabele, Mercy Nkuba Nassali, Modimowame Jamieson, Kyungu M Kime, Chelsea Morroni
Publikováno v:
BMJ Sexual & Reproductive Health. :bmjsrh-2022
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fa1f4fb23d2d11b8e1cc1d745278714
https://doi.org/10.1136/bmjsrh-2022-201748
https://doi.org/10.1136/bmjsrh-2022-201748
Autor:
Rebecca, Howett, Alida M, Gertz, Tiroyaone, Kgaswanyane, Gregory, Petro, Lesego, Mokganya, Sifelani, Malima, Tshego, Maotwe, Melanie, Pleaner, Chelsea, Morroni
Publikováno v:
African journal of reproductive health. 23(4)
The use of the subdermal contraceptive implant is increasing globally, and particularly so in lower- and middle-income countries in sub-Saharan Africa. For initiation or discontinuation of the implant, users need to have access to services for insert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9ccca884b36af9ae0acc5f2a33bc7ef
https://pubmed.ncbi.nlm.nih.gov/32227736
https://pubmed.ncbi.nlm.nih.gov/32227736
Autor:
Alida M. Gertz, Kwana Lechiile, Carolyn Westhoff, Ava Avalos, Aamirah Mussa, Leabaneng Tawe, Tshego Maotwe, Boikhutso Simon, Lesego Mokganya, Sifelani Malima, Nicholas Teodoro, Ian J. Bishop, Serena Liu, Chelsea Morroni
Publikováno v:
Contraception. 102(3)
Objectives To evaluate whether etonogestrel concentrations are reduced to a level that could potentially reduce contraceptive efficacy when the etonogestrel contraceptive implant is used concomitantly with dolutegravir-based antiretroviral therapy (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1559654fa9d8310b3152e63ff56b79d1
https://pubmed.ncbi.nlm.nih.gov/32387328
https://pubmed.ncbi.nlm.nih.gov/32387328
Autor:
Sarah C. Tinker, Cynthia A. Moore, Eldah Dintwa, Shifawu Odunsi, Mpho Letebele, Chipo Petlo, Catherine Motswere-Chirwa, Elizabeth M Rabold, Gadzikanani Gokatweng, Dhelia M. Williamson, Chibuike M Ogbuabo, Kunle Dare, Kelame Kefitlhile, Mmakgomo Mimi Raesima, Surbhi Modi, Vasavi Thomas, Thusoetsile Modise, Sara E. Forhan, Michelle E. Roland, Sifelani Malima, Omphemetse Mmunyane
Publikováno v:
The New England journal of medicine. 381(9)
Dolutegravir Use and Birth Defects in Botswana Identifying birth defects associated with medication use is complex, given the infrequency of events. In this study conducted in Botswana, a slightly ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b654cef594592e484c592155e05698
https://pubmed.ncbi.nlm.nih.gov/31339675
https://pubmed.ncbi.nlm.nih.gov/31339675